Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation
View Patent ↗The present invention relates to the use of antisense oligonucleotides directed against specific nucleic acid sequences coding for receptors, alone or in combination, in order to inhibit the inflammatory reaction that is present in asthma, atopy or hypereosinophilia and to inhibit neoplastic cell proliferation. The antisense oligonucleotides of the present invention are used for treating and/or preventing asthma, allergy, hypereosinophilia, general inflammation or cancer. The oligonucleotides of the present invention are more specifically directed against nucleic acid sequences coding for a CCR3 receptor, a common sub-unit of IL-4 and IL-13 receptors, or a common sub-unit of IL-3, IL-5 and GM-CSF receptors.
1. A pharmaceutical composition comprising an oligonucleotide having a base sequence consisting of SEQ ID NO:9.
2. A pharmaceutical composition for treating asthma or allergy said composition comprising an oligonucleotide having a base sequence consisting of SEQ ID NO:9 in association with a pharmaceutically acceptable carrier.
3. The pharmaceutical composition of claim 2 , further comprising at least one oligonucleotide directed against a nucleic acid encoding a Chemokine (C-C motif) receptor 3 (CCR3).
4. The pharmaceutical composition according to claim 3 , wherein the at least one oligonucleotide with SEQ ID NO: 18 is directed against a nucleic acid encoding a Chemokine (C-C motif) receptor 3 (CCR3).
5. An oligonucleotide having a base sequence consisting of SEQ ID NO:9 and comprising at least one phosphorothioate internucleotide linkage.
6. The oligonucleotide of claim 5 , comprising all phosphorothioate internucleotide linkages.
7. The oligonucleotide of claim 1 , comprising at least one phosphodiester internucleotide linkage.
8. The oligonucleotide of claim 7 , comprising all phosphodiester internucleotide linkages.
9. A pharmaceutical composition for treating asthma or allergy said composition comprising an oligonucleotide having a base sequence consisting of SEQ ID NO:9 and comprising at least one phosphorothioate internucleotide linkage, in association with a pharmaceutically acceptable carrier.
10. A pharmaceutical composition for treating asthma or allergy said composition comprising the oligonucleotide as defined in claim 6 , in association with a pharmaceutically acceptable carrier.
11. A pharmaceutical composition for treating asthma or allergy said composition comprising the oligonucleotide as defined in claim 7 , in association with a pharmaceutically acceptable carrier.
12. A pharmaceutical composition for treating asthma or allergy said composition comprising the oligonucleotide as defined in claim 8 , in association with a pharmaceutically acceptable carrier.